Kymera Therapeutics Inc (KYMR): Eigentümerstruktur
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Kymera Therapeutics Inc
Mitarbeiter 273
Handelsplatz NASDAQ
Ticker Symbol KYMR
IPO Datum 2020-08-21
Adresse 500 North Beacon Street, Watertown, MA, United States, 02472
Webseite https://www.kymeratx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Nello Mainolfi M.D., Ph.D. | Co-Founder, President, CEO & Director |
| 2 | Mr. Bruce N. Jacobs CFA | Chief Financial Officer |
| 3 | Mr. Brian R. Adams J.D. | Chief Legal Officer & Corporate Secretary |
| 4 | Dr. Jared A. Gollob M.D. | Advisor |
| 5 | Mr. Noah Goodman M.B.A. | Chief Business Officer |
| 6 | Ms. Justine E. Koenigsberg | Vice President of Investor Relations |
| 7 | Dr. Neil Graham M.D., M.P.H., MBBS | Chief Development Officer |
| 8 | Mr. Brian Albarran M.B.A., Ph.D. | SVP of Corporate Strategy |
| 9 | Dr. Juliet Williams B.A Ph.D. | Head of Research |
| 10 | Dr. Jeremy G. Chadwick Ph.D. | Advisor |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 14,07% | 1,33 Mrd. USD |
| 2 | Baker Bros Advisors LP | 10,41% | 0,99 Mrd. USD |
| 3 | venBio Select Advisor LLC | 8,99% | 0,85 Mrd. USD |
| 4 | T. Rowe Price Associates, Inc. | 7,29% | 0,69 Mrd. USD |
| 5 | Bvf Inc | 6,62% | 0,63 Mrd. USD |
| 6 | T. Rowe Price Investment Management,Inc. | 6,57% | 0,62 Mrd. USD |
| 7 | BlackRock Inc | 6,09% | 0,58 Mrd. USD |
| 8 | Wellington Management Company LLP | 4,42% | 0,42 Mrd. USD |
| 9 | Siren, L.L.C. | 3,83% | 0,36 Mrd. USD |
| 10 | Vanguard Capital Management, LLC | 3,46% | 0,33 Mrd. USD |
| 11 | Vanguard Portfolio Management, LLC | 3,46% | 0,33 Mrd. USD |
| 12 | Atlas Venture Life Science Advisors, LLC | 3,42% | 0,32 Mrd. USD |
| 13 | State Street Corp | 2,87% | 0,27 Mrd. USD |
| 14 | Geode Capital Management, LLC | 1,98% | 0,19 Mrd. USD |
| 15 | Capital Research Global Investors | 1,67% | 0,16 Mrd. USD |
| 16 | Driehaus Capital Management LLC | 1,26% | 0,12 Mrd. USD |
| 17 | UBS Group AG | 1,23% | 0,12 Mrd. USD |
| 18 | The Goldman Sachs Group Inc | 1,07% | 0,10 Mrd. USD |
| 19 | AllianceBernstein L.P. | 1,07% | 0,10 Mrd. USD |
| 20 | UBS Asset Mgmt Americas Inc | 1,05% | 0,10 Mrd. USD |